Figure 5.
(a) Raloxifene hydrochloride release profile from CS-RAL, KER-RAL, and CS/KER-RAL over 12 weeks; (b) Raloxifene hydrochloride release profile from CS-RAL, KER-RAL, and CS/KER-RAL during the first 24 h.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.